LMAT News and Press, LeMaitre Vascular Inc. From 02/06/20

BURLINGTON, Mass., Feb. 06, 2020 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q4 2019 results, provided guidance, and announced a $0.095/share dividend. Q4 2019 Results Record sales of $30....

BURLINGTON, Mass., Jan. 29, 2020 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its fourth quarter 2019 financial results on Thursday, February 6, 2020, after the market close. The company has scheduled a conference call for 5:00 PM EST the sa...

The human circulatory system is amazing. But it doesn’t always run smoothly. Roughly 3% of the living population suffers from some sort of peripheral vascular disease (PVD), explains Tyler Laundon , editor of Cabot Small-Cap Confidential . This occurs when there are iss...

BURLINGTON, Mass., Jan. 03, 2020 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will present at the 22 nd Annual Needham Growth Conference on Wednesday, January 15, 2020 at the Lotte New York Palace Hotel in New York C...

Introduction The Dividend Champions list is a monthly compilation of companies which have consistently increased their annual dividend payouts, and the latest edition may be found here . However, since this list is only produced once per month, the data in it can quickly get out of date. Fu...

Introduction The Dividend Champions list is a monthly compilation of companies which have consistently increased their annual dividend payouts, and the latest edition may be found here . However, since this list is only produced once per month, the data in it can quickly get out of date. Fu...

Benjamin Graham wrote in his book The Intelligent Investor : It always seemed, and still seems, ridiculously simple to say that if one can acquire a diversified group of common stocks at a price less than the applicable net current assets alone-after deducting all prior claims and coun...

ACADIA Pharmaceuticals (NASDAQ: ACAD ) initiated with Market Perform rating and $44 (5% upside) price target at Oppenheimer. More news on: ACADIA Pharmaceuticals Inc., Nektar Therapeutics, Neovasc Inc., Healthcare stocks news, Stocks on the move, , Read more ...

Image source: The Motley Fool. LeMaitre Vascular   (NASDAQ: LMAT) Q3 2019 Earnings Call Oct 23, 2019 , 5:00 p.m. ET Operator Continue reading

LeMaitre Vascular, Inc. (LMAT) Q3 2019 Earnings Conference Call October 23, 2019 5:00 PM ET Company Participants J.J. Pellegrino - Chief Financial Officer George LeMaitre - Chairman & Chief Executive Officer Dave Roberts - President Conference Call Participants Jim Sido...